Market revenue in 2023 | USD 1.3 million |
Market revenue in 2030 | USD 1.7 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Bioavailability & bioequivalence studies |
Fastest growing segment | Bioavailability & Bioequivalence Studies |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Other test type |
Key market players worldwide | IQVIA Holdings Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, Charles River Laboratories International Inc, Syneos Health, Intertek Group PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy bioanalytical testing services market will help companies and investors design strategic landscapes.
Bioavailability & bioequivalence studies was the largest segment with a revenue share of 38.46% in 2023. Horizon Databook has segmented the Kuwait cell & gene therapy bioanalytical testing services market based on bioavailability & bioequivalence studies, pharmacokinetics, pharmacodynamics, other test type covering the revenue growth of each sub-segment from 2018 to 2030.
Kuwait's market for cell and gene therapy bioanalytical testing services is anticipated to grow significantly due to the country's ability to generate novel medications locally, access to valuable products, the growing need for new medical therapies, and favorable regulatory frameworks.
Furthermore, the increasing acceptance of gene treatments is projected to create opportunities for cell and gene therapy in Kuwait. Another significant driver of market growth is the establishment and expansion of products in the country.
Thus, an increase in research activities, pharmaceutical companies, and government support for drug development are anticipated to propel market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait cell & gene therapy bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait cell & gene therapy bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account